Congress·Reported·S. 527

Prescription Pricing for the People Act of 2025

Prescription Drugs: Study of Supply Chain Middlemen

Apr 10, 2025·View on Congress.gov·Read full text

This bill is one vehicle in a longer effort. See the full story across every version.View effort →

Next up: The SenateNo action in 15 months

This bill has been approved by the Senate Judiciary Committee and is now waiting for a vote by the full Senate. It is currently placed on the legislative calendar and is actively moving forward. There is no companion bill mentioned at this time.

Legislative Progress

Senate

House

President

Law

Likely to pass

This bill has strong bipartisan support and has already been approved by a major Senate committee, making it very likely to pass the full Senate.

How we got here

This bill’s path across every version that has carried it.

Reintroduced
Reintroduced from S. 113 (118th), which died when its Congress ended.
S. 113 (118th) →

Key Points

This bill requires the Federal Trade Commission to conduct a deep dive into the companies that sit between drug makers and patients. These companies help decide which medicines your insurance covers and how much you pay at the pharmacy counter.
The investigation will look at whether these middlemen are using unfair tactics to make more money. This includes checking if they steer patients toward pharmacies they own or if they favor expensive drugs over cheaper ones just to get bigger rebates from drug makers.
The goal is to find out if these secret business deals are the reason why many Americans struggle to afford their prescriptions. The government wants to see if these companies are hurting small, local pharmacies by giving themselves an unfair advantage.
The Federal Trade Commission must give a progress report to Congress in six months and a final report with solutions in one year. This report will include specific ideas for new laws to stop unfair behavior and help lower costs for families.

Impact Analysis

Govbase has not yet run an impact analysis on this legislation.

Milestones

4 milestones5 actions

Apr 10, 2025Senate

Placed on Senate Legislative Calendar under General Orders. Calendar No. 42.

The bill is now on the schedule for the full chamber to consider. It's in line for debate and a vote.

Apr 10, 2025Senate

Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.

The committee approved this bill and is sending it to the full chamber for a vote. This is a significant step — most bills never get this far.

Apr 3, 2025Senate

Committee on the Judiciary. Ordered to be reported without amendment favorably.

The committee approved this bill and is sending it to the full chamber for a vote. This is a significant step — most bills never get this far.

Feb 11, 2025Senate

Read twice and referred to the Committee on the Judiciary.

Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.

Feb 11, 2025

Introduced in Senate

The bill was officially filed and given a number. It now enters the legislative queue.

No votes, news coverage, or related bills recorded for this bill yet.

Source Information

Document Type

Congressional Bill

Official Title

Prescription Pricing for the People Act of 2025

Bill NumberS 527

Congress119th Congress

ChamberSenate

Latest ActionPlaced on Senate Legislative Calendar under General Orders. Calendar No. 42.

Data Sources

Congress.gov

Official legislative information

Read Full Bill Text

Sponsor

Cosponsors

(13)

D: 6R: 7

Analysis generated by AI. Always verify with official sources.